Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.62 USD
Change Today -0.11 / -4.03%
Volume 88.3K
GALT On Other Exchanges
As of 8:10 PM 07/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Harold H. Shlevin Ph.D.

Chief Operating Officer and Corporate Secretary, Galectin Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 26 board members in 3 different organizations across 7 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Harold H. Shlevin, Ph.D., has been Chief Operating Officer of Galectin Therapeutics, Inc., since October 1, 2012. Dr. Shlevin was a Principal and Head of Bioscience Commercialization at Advanced Technology Development Center at Georgia Institute of Technology. He is a Biosciences Startup Catalyst at Advanced Technology Development Center. He is a 30-year bioscience-industry executive with broad senior management experience in medical devices, pharmaceuticals, diagnostics ...

Read Full Background

Corporate Headquarters*

4960 Peachtree Industrial Boulevard
Norcross, Georgia 30071

United States

Phone: 678-620-3186
Fax: 770-864-1327

Board Members Memberships*

Former Chief Executive Officer and President and Member of Pharmaceutical Management Committee
Former Chief Executive Officer, President and Director
Director, Chairman of Compensation Committee and Member of Corporate Governance & Nomination Committee


Bachelor's Degree
Boston University
University of Rochester Medical Center
Master's Degree
University of Rochester Medical Center
Master's Degree
Mayo Graduate School

Other Affiliations*

Annual Compensation*

Total Annual Compensation$307,625

Stock Options*

All Other Compensation$35,304
Exercisable Options168,212
Exercisable Options Value$172,500
Unexercisable Options19,788
Total Value of Options$172,500
Total Number of Options188,000

Total Compensation*

Total Annual Cash Compensation$342,929
Total Short Term Compensation$307,625
Other Long Term Compensation$35,304
Total Calculated Compensation$771,748
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GALT:US $2.62 USD -0.11


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GALECTIN THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at